{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:59:35Z","timestamp":1775037575665,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T00:00:00Z","timestamp":1595462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008782","name":"University of Hawai'i","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008782","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.gore.2020.100614","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T13:48:06Z","timestamp":1595857686000},"page":"100614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Novel immunohistochemical markers in the differential diagnosis of endocervical and endometrial adenocarcinoma: The added benefit of CAIX and PAX8"],"prefix":"10.1016","volume":"33","author":[{"given":"Ana I.","family":"Hernandez-Caballero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koah R.","family":"Vierkoetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeong Jun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Terada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2020.100614_b0005","first-page":"4","article-title":"Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study","volume":"21","author":"Castrillon","year":"2002","journal-title":"Int. J. GynecolPathol."},{"issue":"6","key":"10.1016\/j.gore.2020.100614_b0010","doi-asserted-by":"crossref","first-page":"937","DOI":"10.5114\/aoms.2010.19305","article-title":"Long-term survival of endometrioid endometrial cancer patients","volume":"6","author":"Gottwald","year":"2010","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.gore.2020.100614_b0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1746-1596-2-40","article-title":"Primary endometrioid adenocarcinoma of the cervix with widespread squamous metaplasia \u2013 a potential diagnostic pitfall","volume":"2","author":"Hirschowitz","year":"2007","journal-title":"Diagn. Pathol."},{"issue":"3","key":"10.1016\/j.gore.2020.100614_b0020","first-page":"219","article-title":"Hypoxia and angiogenesis in endometrioid endometrial carcinogenesis","volume":"29","author":"Horr\u00e9e","year":"2007","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.gore.2020.100614_b0025","first-page":"217","article-title":"Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: another viewpoint","volume":"21","author":"Kamoi","year":"2002","journal-title":"Int. J. GynecolPathol."},{"issue":"2","key":"10.1016\/j.gore.2020.100614_b0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.0006-341X.2000.00345.x","article-title":"Comparisons of predictive values of binary medical diagnostic tests for paired designs","volume":"56","author":"Leisenring","year":"2000","journal-title":"Biometrics"},{"issue":"2","key":"10.1016\/j.gore.2020.100614_b0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5858\/arpa.2015-0081-OA","article-title":"Assessment of the utility of PAX8 immunohistochemical stain in diagnosing endocervical glandular lesions","volume":"140","author":"Liang","year":"2016","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.gore.2020.100614_b0040","unstructured":"National Comprehensive Cancer Network, 2020. Uterine neoplasms. Retrieved from https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx."},{"issue":"2","key":"10.1016\/j.gore.2020.100614_b0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/gyno.2000.5826","article-title":"The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States\u2013a 24-year population-based study","volume":"78","author":"Smith","year":"2000","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.gore.2020.100614_b0050","doi-asserted-by":"crossref","first-page":"254","DOI":"10.21147\/j.issn.1000-9604.2016.02.11","article-title":"Biology and treatment of cervical adenocarcinoma","volume":"28","author":"Takeuchi","year":"2016","journal-title":"Chin. J. Cancer Res."},{"issue":"5","key":"10.1016\/j.gore.2020.100614_b0055","first-page":"492","article-title":"PAX8 expression in uterine adenocarcinomas and mesonephric proliferations","volume":"33","author":"Yemelyanova","year":"2014","journal-title":"Int. J. GynecolPathol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578920300801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578920300801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:56:33Z","timestamp":1762480593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578920300801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":11,"alternative-id":["S2352578920300801"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2020.100614","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel immunohistochemical markers in the differential diagnosis of endocervical and endometrial adenocarcinoma: The added benefit of CAIX and PAX8","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2020.100614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100614"}}